Skip to main content

Table 4 Outcomes and survival analysis

From: Liver resection of hepatocellular carcinoma in HIV-HCV co-infected patients: a retrospective case series

  HIV+/HCV+ HIV−/HCV− p-value
Days of hospitalization
°Mean ± SD 9.6 ± 4.45 10.81 ± 3.71 0.6
Complications, n (%) 2 (40) 8 (72.72) 0.299
Clavien-Dindo score, mean ± SD 1 ± 1.41 1.36 ± 1.2 0.594
°< 2 4 (80) 10 (90.91) 0.99
°> 2 1 (20) 1 (9.09)
Comprehensive complication index
°Mean ± SD (min; max) 12.8 ± 17.6 (0; 34) 12.7 ± 11.2 (0; 34) 0.815
°Median (25; 75° percentile) 0 (0; 30) 9 (4.5; 21.5)  
Postoperative ascites, n (%) 0 2 (18.18) 0.99
Overall survival (months)
°Mean ± SE 36 ± 2.59 29.9 ± 3.49 0.443
°Death, n (%) 1 (20) 4 (36.36) 0.99
°OS at 1 year 100% 90%  
°OS at 3 years 75% 53.3%  
Recurrence-free survival (months)
°Mean ± SE 27 ± 5.69 26.78 ± 4.41 0.873
°Relapse, n (%) 2 (40) 4 (36.36) 1
°RFS at 1 year 80% 80.8%  
°RFS at 3 years 53.3% 58.9%  
Type of relapse, n (%)
°Extrahepatic, n (%) 0 0  
°Intrahepatic, n (%) 2 4  
°Local recurrence, n (%) 0 2 (50) 0.467
°Distant intrahepatic, n (%) 2 (100) 2 (50)
Treatment of relapse, n (%)
°Liver resection 0 0  
°Termoablation 0 1 (25)  
°Liver transplant 1 (50) 0  
°TACE 0 0 0.20
°Medical treatment 0 3 (75)  
°Palliative treatment 1 (50) 0  
°Other 0 0  
  1. SD standard deviation, SE standard error